AR signaling was shown to activate CXCR4 protein expression through KLF5 in prostate cancer cells, propelling chemotactic migration in response to CXCL12, a chemokine abundantly present in the microenvironment and specific sites of metastasis [104,105]. Here, KLF5 is linked to prostate cancer.